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Abstract
The Mutant Mouse Resource and Research Center (MMRRC) Program is the pre-eminent public national mutant mouse 
repository and distribution archive in the USA, serving as a national resource of mutant mice available to the global scientific 
community for biomedical research. Established more than two decades ago with grants from the National Institutes of Health 
(NIH), the MMRRC Program supports a Consortium of regionally distributed and dedicated vivaria, laboratories, and offices 
(Centers) and an Informatics Coordination and Service Center (ICSC) at three academic teaching and research universi-
ties and one non-profit genetic research institution. The MMRRC Program accepts the submission of unique, scientifically 
rigorous, and experimentally valuable genetically altered and other mouse models donated by academic and commercial 
scientists and organizations for deposition, maintenance, preservation, and dissemination to scientists upon request. The four 
Centers maintain an archive of nearly 60,000 mutant alleles as live mice, frozen germplasm, and/or embryonic stem (ES) 
cells. Since its inception, the Centers have fulfilled 13,184 orders for mutant mouse models from 9591 scientists at 6626 
institutions around the globe. Centers also provide numerous services that facilitate using mutant mouse models obtained 
from the MMRRC, including genetic assays, microbiome analysis, analytical phenotyping and pathology, cryorecovery, 
mouse husbandry, infectious disease surveillance and diagnosis, and disease modeling. The ICSC coordinates activities 
between the Centers, manages the website (mmrrc.org) and online catalog, and conducts communication, outreach, and 
education to the research community. Centers preserve, secure, and protect mutant mouse lines in perpetuity, promote rigor 
and reproducibility in scientific experiments using mice, provide experiential training and consultation in the responsible 
use of mice in research, and pursue cutting edge technologies to advance biomedical studies using mice to improve human 
health. Researchers benefit from an expansive list of well-defined mouse models of disease that meet the highest standards 
of rigor and reproducibility, while donating investigators benefit by having their mouse lines preserved, protected, and dis-
tributed in compliance with NIH policies.
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Accelerating the use of mutant mice 
in biomedical research
Beginning in the early 1990’s, a nearly three decade 
expansion of the repertoire of mouse models that could be 
used experimentally for the study of human diseases began 
(Davisson and Taft 2006; Gurumurthy and Lloyd 2019). 
Sequential emergence and experimental application of a 
myriad of technologies, including ethylnitrosurea (ENU) 
mutagenesis, homologous recombination in embryonic 
stem (ES) cells, transgenic, conditional targeting (e.g., 
Cre), transposons, and programmable endonucleases 
(e.g., CRISPR/Cas9) all contributed to a rapid growth in 
the design, development, and production of a variety of 
mutant mice for biomedical research. Eventually, the few 
commercial and not-for-profit mouse distributors that were 
archiving and maintaining these new mouse lines were 
becoming overwhelmed, precipitating risky and capri-
cious trafficking of mice among individual investigator 
laboratories, often with naive disregard of quality control 
standards, genetic fidelity, contamination with adventitious 
pathogens, or the spread of transmissible infections. As 
a consequence, many mouse lines were unavailable or if 
available unaccessible, and those that could be obtained 
were often unreliable due to poorly characterized and 
often erroneous genotype, insufficient documentation, or 
poor health. In turn, results published using these mod-
els failed replication, preclinical research using animals 
became unpredictable and irreproducible, and scientific 
progress was being hampered. These and other challenges 
were spreading widely, and the reliability and reproduc-
ibility of scientific results using mice (and other animals) 
was being seriously questioned, especially in translational 
preclinical studies (Kilkenny 2009).
A trans‑national network of non‑profit 
mouse repositories
In response to these mounting pressures, the US National 
Institutes of Health (NIH) in 1998 convened a panel of 
internationally renowned scientists to draft recommenda-
tions for facilitating broad but controlled access to mouse 
resources under rigorous quality control standards (Battey 
1999). The top recommendation of this group was for the 
federal government to create a consortium of archive and 
distribution repositories to solicit, accept, import, validate, 
maintain, preserve, and disseminate mutant mouse lines, 
especially those generated by NIH-funded researchers 
and laboratories. Although expected to have the scientific 
expertise, experience, capability, and capacity to manage 
mice and mouse resources, NIH-supported repositories 
were first and foremost tasked with serving as an unre-
stricted resource of the burgeoning mutant mouse lines 
for experimental use by the academic research community. 
Second, they were mandated to contribute to science and 
technology to enhance and develop their holdings, such 
as research into embryo cryopreservation and archiving 
frozen germplasm. Third, repositories were to serve the 
broad research community in diverse disease areas, and 
not focus on a particular category of mouse resource or 
disease area. Fourth, they were to make mice available to 
the research community on a local, regional, and national 
(and eventually international) basis, irrespective of where 
the repositories were located geographically. Finally, 
funded repositories were expected to have robust animal 
infrastructure (vivaria, technicians, veterinary and labo-
ratory support), mouse husbandry and care experience, 
and infectious and genetic quality control and assurance 
standards and policies in place to ensure research repro-
ducibility and integrity. These characteristics have since 
become fundamental expectations of centralized mouse 
repository systems worldwide (Donahue 2012).
Birth of the MMRRC 
What arose from these discussions was the creation by 
NIH of an extramural Mutant Mouse Regional Resource 
Center (MMRRC) Program which was intended to fund 
competitive applications from public and private entities 
committed to accepting, maintaining, and disseminating 
mutant mouse models to the biomedical research com-
munity (Grieder 2002). The first Request for Applications 
(RFA-RR-99-001) was issued by the NIH National Center 
for Research Resources (NCRR; now under the authority of 
the NIH Office of Research Infrastructure Programs [ORIP], 
Division of Program Coordination, Planning, and Strategic 
Initiatives [DPCPSI], Office of the Director) which officially 
established the MMRRC Program as the nation’s premier 
publicly accessible mutant mouse archive and distribu-
tion repository system. The MMRRC was rechristened in 
2014 as the Mutant Mouse Resource and Research Center 
to reflect the expansion of its mission to include resource-
related research that is intended to promote greater effective-
ness and efficiencies in service to the biomedical research 
community without bias for a particular category of mouse 
model or research. In practical terms, the MMRRC Program 
provided funding to host institutions willing to participate 
in a national Consortium of individual, regionally distrib-
uted Centers with dedicated infrastructure (including bar-
rier housing and microbial quality control), cryopreservation 
and reconstitution capabilities, proven standard operating 
procedures (SOPs) and surveillance protocols for infectious 
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pathogens and environmental contaminants, and sufficient 
professional, scientific, and technical expertise in quality 
control and other activities to maintain the genetic integrity 
of mice and germplasm at first, then later murine embryonic 
stem (ES) and hybridoma cell lines.
The first NIH awards establishing archive and distribution 
Centers were made in 1999, two to academic institutions 
(UC Davis and UNC-Chapel Hill) and two to commercial/
academic partnerships (Harlan/University of Missouri-
Columbia and Taconic/SUNY-Albany) which together with 
a separately funded Informatics, Coordination and Service 
Center (ICSC) collectively became known as the MMRRC 
Consortium. At the first competitive renewal in 2005, the 
two commercial partners had left the MMRRC Consortium 
while funding was awarded to the University of Missouri-
Columbia to operate alone as the third Center. In response to 
the growth and success of the three academic-based Centers 
during the first 10 years of funding, at the 2nd competitive 
renewal in 2010 The Jackson Laboratory was added as the 
fourth Center. All four Centers then successfully renewed 
in 2015 and again in 2020. Today, each Center exists in 
a research-intensive environment that synergizes with in-
house genetic and programmatic resources and expertise 
that reinforces the MMRRC Program mission (Table 1) 
and engages in close coordination and working relationship 
between Centers.
The original mandate of the Centers participating in the 
MMRRC Consortium was to accept, maintain, and distrib-
ute mutant mice to the scientific community. This approach 
would ensure the viability, genetic identity and background, 
pathogen-free status, and long-term availability of valuable 
mutant mouse models for research. The four Centers operate 
under a common umbrella of SOPs that define best practices 
for the operation of a twenty-first century mouse archive and 
distribution repository system (Table 2).
Centers harmonized internal SOPs within the MMRRC 
Consortium while maximizing individual efficiencies. The 
Centers began serving as centers of excellence in mouse 
biology and phenotyping, thereby facilitating and extend-
ing the validity, reproducibility, and scientific value of these 
models. In some cases they have also earned “approved 
vendor” status from institutions of requesting investigators, 
facilitating direct import of mice into research colonies 
which bypasses costly delays associated with importation 
quarantines and rederivation.
Opening its doors for business
When launched, Centers within the MMRRC Consortium 
began accepting applications from investigators to submit 
their mutant mouse lines for archiving and distribution. It 
was at this time that the variety and types of mouse lines…
from those derived from ethylnitrosurea (ENU) injection 
into male mice, random gene and promoter trap experi-
ments in murine ES cells, mice expressing specific recom-
bination enzymes (CRE, FLP), to a host of new transgenic 
and knockout mice. Within a year, the MMRRC Program 
was adapting to this changing environment and broadening 
opportunities for acceptance of a wider variety of mouse 
lines by establishing three types of submissions (Table 3). 
Most submissions were categorized as Type 1 in which a 
mutant mouse line was developed and characterized by the 
donating investigator. Type 1 submission applications are 
reviewed monthly by video teleconference of a Coordinat-
ing Committee made up of the principal investigators of the 
Centers and ICSC and NIH program officials. These reviews 
are intended to determine whether an application for a Type 
1 submission fulfills the following six criteria:
Table 1  Location and web addresses of (current) Centers in the 
MMRRC Consortium
*Initially in partnership with Harlan, then established independently 
2005
Host Institution (year established) Web Address
University of Missouri, Columbia (1999*) mmrrc.missouri.edu
University of California, Davis (1999) mmrrc.ucdavis.edu
The Jackson Laboratory (2010) jax.org/mmrrc
University of North Carolina, Chapel Hill 
(1999)
med.unc.edu/mmrrc
Table 2  MMRRC consortium 
best practices All MMRRCs observe best practices in the following activities:
 Importation, rederivation, maintenance (e.g., husbandry, care, and welfare), and distribution
 Cryopreservation and recovery, pathogen surveillance and health monitoring, mouse genetics
 Information technology, database management, and website and online services
 Communications, outreach, and education
Table 3  Types of mouse submissions to the MMRRC Program
MMRRC donation type Description
Type 1 Individual donating investigators
Type 2 NIH Program Officer-sanctioned mice/lines
Type 3 Contract to individual center
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• Created and analyzed using sound scientific methods;
• Distinguishable genotypically and/or phenotypically 
from other publicly available lines;
• Exhibits scientifically rigorous and experimentally repro-
ducible findings;
• Exists at no other public distribution repository;
• Available for distribution without restriction to academic 
researchers, and
• Controls are readily available or can be provided by the 
submitting investigator.
Although not required, a scientific publication or readily 
accessible phenotype data (e.g., via a web-based resource) 
describing the creation and study of the submitted mouse 
line adds considerable scientific data and documented evi-
dence to facilitate review. Generally, a mouse line must meet 
all criteria to be accepted into the MMRRC. Upon review, 
MMRRC ICSC staff will work with the submitting investi-
gator to obtain additional details or provide other options 
for depositing into the MMRRC (e.g., Type 3 donation) 
if their mouse line fails to meet acceptance criteria. The 
only cost to the submitting investigator is that incurred by 
shipping mice to the assigned Center. Other than that, all 
importation, rederivation, quality control testing, mainte-
nance, and archiving costs are borne by NIH funds awarded 
to the host institution to support the Center. For example, 
once imported into the Center’s repository, tissue samples 
are taken for DNA extraction to confirm genotype of the 
mutant allele and genetic background, fecal pellets are har-
vested (or collected earlier by the submitting investigator 
before shipping mice) for microbiome analysis, mice are 
bred (if necessary) to generate live colonies, and sperm and/
or embryos are cryoarchived. Mice are listed as available 
for distribution by browsing or searching the online catalog 
once fully curated and after confirmation of gene-specific 
genotype and genetic background, establishment of a cryo-
preserved archive and verification of viable cryorecovery, 
determination of pathogen-free status, and exclusion of unin-
tended or contaminating DNA elements (e.g., Cre). Proceeds 
derived from modest fees charged to requesting investigators 
to obtain and ship mouse lines to requesting investigators 
provides program income to support distribution costs (e.g., 
cryorecovery supplies, technical effort, genotyping, holding 
costs, etc.) incurred by the Center.
Type 2 and Type 3 submissions undergo a similar level 
of rigorous assessment and review yet because of their ori-
gin or other special characteristics do not go through the 
same formal application process as Type 1 submissions. 
For example, the MMRRC Program provides a very limited 
number of Type 2 submission “slots” that are pre-selected 
by NIH categorical institutes for fast-track acceptance of 
mice from their funded scientists into the MMRRC. Type 3 
submissions are primarily secured as large, thematic collec-
tions that were produced by large consortiums, commercial 
organizations, and/or private research entities. Some of these 
collections are submitted and made available for distribu-
tion as gene-targeted ES cells, several of which have been 
converted into mice and are available as frozen germplasm. 
As a result, over time the number of Type 3 mouse lines has 
significantly exceeded the number of either Type 1 or Type 
2 mouse lines deposited into the MMRRC (Table 4). 
Donation of mouse lines to the MMRRC 
The growth in number of holdings in the MMRRC Program 
has increased over the last 20 years to a total of 60,751 
unique mutant alleles (Fig. 1), making it one of the larg-
est public repositories of mutant mouse lines in the world 
today. These lines are available in one of more forms as live 
mice, frozen germplasm, and/or pluripotent ES cell lines or 
hybridomas (Fig. 2). These models are useful for research 
in many disease categories including oncology, cardiology, 
immunology, and neurology, developmental biology, and to 
study specific syndromes and diseases. Investigators inter-
ested in submitting their mouse line to the MMRRC Pro-
gram can submit information online through the MMRRC 
Table 4  Mutant mouse lines accepted into the MMRRC Program
Deposition type Cumulative 
(2000–
2020)
Type 1: Investigator initiated, MMRRC Program sup-
ported
1872
Type 2: NIH initiated, MMRRC Program supported 234











































Fig. 1  The cumulative annual increase in MMRRC Program holdings 
of unique mutant alleles and hybridoma cell lines beginning in 2002 
to March 1, 2021. The change each year reflects the sum of all sub-
missions (Type 1, Type 2, and Type 3) accepted and imported into the 
MMRRC repositories during that year
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website (https:// www. mmrrc. org/ submi ssion/ strain_ submi 
ssion_ terms. php), contact the Strain Acquisition Coordinator 
at the ICSC, or contact the Import Coordinator at any of the 
Centers for more information, assistance, and instructions. 
Distribution of mouse lines from the MMRRC 
The number of researchers using the MMRRC Program and 
the number of orders for mutant mouse lines have stead-
ily increased since the MMRRC Consortium started opera-
tions. For example, the number of unique users has averaged 
over 1276 per year over each of the last 5 years to a total 
of 16,303 by the end of 2020 (Fig. 3). Despite the recent 
and temporary drop in orders resulting from the impact of 
the global SARS-CoV-2 pandemic on research activity and 
onsite laboratory work during most of 2020, this number 
of users has translated into a substantial number of orders 
received and fulfilled overtime by the MMRRC since open-
ing its doors (Table 5). Many researchers are returning cus-
tomers who request not only additional mouse lines but also 
special services from a Center through their host institution. 
In addition, with the implementation of a system of unique 
Research Resource Identifiers (RRID; https:// scicr unch. org/ 
resou rces) (Bandrowski and Martone 2016) to search rele-
vant databases (e.g., PubMed), at least 1924 research articles 
have been published to date using mouse lines obtained from 
the MMRRC Program (Fig. 4). This number of publications 
is surely an underrepresentation, as past publications often 
neglect to cite the MMRRC. New articles are discovered 
daily, reflecting the ongoing importance of the MMRRC 
Program as a vital public resource for research using mutant 
mice.  
Live Mice Cryopreserved Germplasm(1) Cells(2)
Proporon of MMRRC Holding Formats
(as of 2021)
Fig. 2  The proportional distribution of various formats (live, cryopre-
served germplasm, cell lines) for all MMRRC holdings as of 2021. 
The number of mouse lines maintained as live breeding colonies is 
small relative to the germplasm and cell archives and reflects those 
lines undergoing active importation and awaiting cryopreservation 
and/or being actively distributed in response to orders for live mice; 
(1) a mutant allele maintained as a frozen embryo and/or sperm; (2) 
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Fig. 3  The number of unique researchers annually who ordered from 
the MMRRC repositories each year between 2015 and 2020. The sud-
den dropoff of orders during 2020 has been attributed to the effects of 
the temporary shutdown of non-essential research activity and shut-


























Fig. 4  Annual number of peer-reviewed publications that cite or 
acknowledge ordering mice, germplasm, or cell lines from the 
MMRRC repositories between 2008 and 2020. As of March 1, 2021, 
a total of 1,924 publications have cited or acknowledge the use of 
the MMRRC. Unfortunately, because not all reseachers who publish 
remember to cite usage of the MMRRC, these numbers underrepre-
sent the actual number of publications reporting on the use of mice, 
germplasm, or cell lines obtained from the MMRRC repositories
Table 5  Orders for mutant 
mouse lines from the MMRRC 
Program
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Enhancing capacity to improve resource 
quality
As experts in mouse biology and related research, each 
Center also provides a number of ancillary services and 
procedures that can be accessed by users of the MMRRC. 
These services include colony management and breeding, 
assisted reproductive technologies, ES cell and microin-
jection, transgenic and other production (CRISPR/Cas9) 
approaches, genotyping and genetic analysis, in vivo and 
ex vivo phenotyping, clinical diagnostics, and anatomic 
pathology. Individuals, institutions or consortia may 
arrange for the acquisition, importation, cryopreservation 
and distribution of individual mouse lines or collections 
on a fee-for-service basis from a Center. A table of avail-
able services and contact information at each Center can 
be found at https:// www. mmrrc. org/ about/ membe rs. php
Conducting resource‑related scientific 
research
A critical component of the MMRRC Program is innova-
tive research that enhances resource operations and services, 
such as developing optimal and more efficient means of 
cryopreservation, re-animation, genotyping, infectious dis-
ease control, and microbiome analysis. These efforts have 
included improvements in cryopreservation and recovery of 
C57BL/6J and C57BL/6N sperm and embryos (Li 2014; 
Mochida 2012), refinement of in vitro fertilization (IVF) 
and intracytoplasmic sperm injection (ICSI) procedures (Li 
2015,2003), enhanced isolation, purification, and gene tar-
geting in murine ES cells (Pettit 2009), development of high-
density SNP genotyping panels (Mouse Universal Genotyp-
ing Arrays [MUGA]) to define genetic background and for 
speed congenics (Sigmon 2020), improved pathogen detec-
tion assays (Ericsson 2017), genome editing technologies 
(CRISPR/Cas9) (Modzelewski 2018) and the establishment 
of strategies by which to provide requesting investigators 
with mice on select complex microbiota (Hart 2018; Erics-
son et al. 2017). In this way, the MMRRC Program is con-
stantly adapting to the rapidly changing needs of the scien-
tific community by mitigating negative impacts of growing 
mouse populations on the nation’s infrastructure. Further, 
electronic networking and innovative data management that 
enables integration of data and information from multiple 
sites, automated tools, curation, attention to cybersecurity, 
and quality control have been incorporated by the ICSC into 
the MMRRC Consortium. Centers provide training and pro-
fessional expertise to maximize their impact and access by 
the scientific community.
Coordination between centers in the MMRRC 
consortium
Centers and ICSC PIs in addition to meeting monthly con-
vene with NIH program staff annually in person to dis-
cuss complex programmatic and strategic planning, allow-
ing time to critically and objectively review and assess 
consortium-wide operational and performance metrics, 
discuss research goals and accomplishments, and develop 
strategies to address the evolving needs of the biomedi-
cal research community. Biennially these meetings are in 
association with the NIH-ORIP Resource Directors’ Meet-
ing in Bethesda, Maryland. On alternate years, individual 
Centers host MMRRC Consortium meetings at their host 
institutions. An External Advisory Committee of five tech-
nical specialists and research scientists attend and provide 
critical review and valuable feedback on MMRRC Pro-
gram performance and planning to which the MMRRC 
Consortium responds with action items and point-by-
point reports. These individuals also serve to represent 
the scientific community and advise Center leadership on 
ways to enhance and improve the provision and delivery 
of services to its users. In addition, the MMRRC Consor-
tium has established a number of internal working groups 
which facilitate collective discussions to address issues, 
challenges, and opportunities in management, administra-
tion, technology, intellectual property, research, and other 
areas that help the MMRRC Program continue to evolve 
and develop to effectively meet the needs of the research 
community.
An emphasis on serving scientific needs
A primary goal of the MMRRC Program is to present a 
single, unified, online presence to best serve its customers. 
The ICSC coordinates customer service by maintaining a 
public web site (www. mmrrc. org) with access to a search-
able repository catalog, an ordering and submission sys-
tem, and centralized customer service support. Customer 
service staff at the ICSC are knowledgeable on all aspects 
of MMRRC Program services. Customers can communi-
cate with customer service staff through dedicated MMRRC 
telephone numbers (800-910-2291 [North America], 530-
757-5710 [international]), email addresses (servi ce@ mmrrc. 
org, suppo rt@ mmrrc. org), and a service request tracking 
system. Standard customer operating procedures, including 
templates and institutional tracking of intellectual property 
issues, support both donors and purchasers and their affili-
ated research institutes as well as facilitate seamless coor-
dination between all Centers in the MMRRC Consortium.
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Unified community outreach and education
The MMRRC promotes a unified identity to increase 
awareness of mouse resources within the research com-
munity. The MMRRC brand is used across all outreach 
materials, such as the MMRRC booth which ICSC staff 
take to scientific meetings, print and online advertisement, 
and pamphlets, buttons, and other collateral distributed at 
meetings and within outgoing shipments. The MMRRC 
Program is continuously developing new  promotional 
methods to build awareness of its repository holdings and 
value-added services. Although together the Centers house 
a large number of mouse lines with a variety of pheno-
types, usage depends completely on customer awareness. 
The ICSC profiles researchers based on their publications 
and correlates research interests with repository hold-
ings. This information is then distributed through highly 
customized emails to inform researchers of specific and 
potentially useful mice and services for their research. The 
same system is used to solicit the submission of newly 
published mouse models. The immediate success of this 
system has been demonstrated by an increase in number 
of strain submissions, flow of traffic to the MMRRC web 
site, and volume of catalog searches. Comprehensive tools 
for assessing the impact of email campaigns are utilized 
to enhance their efficacy and to facilitate customer service 




The MMRRC Program actively pursues opportunities 
to engage and interact with similar and complementary 
resources and entities. For example, the ICSC offers 
openly available, automatic updates of the mouse hold-
ings at each Center. Popular subscribers include PubMed 
(https:// pubmed. ncbi. nlm. nih. gov/), the Online Mendelian 
Inheritance of Man (OMIM, www. omim. org), the Inter-
national Mouse Strain Resource (IMSR, http:// www. findm 
ice. org/), the Mouse Genome Informatics (MGI, http:// 
www. infor matics. jax. org/), and the International Mouse 
Phenotyping Consortium (IMPC, https:// www. mouse 
pheno type. org/). Together with the MMRRC these organ-
izations represent a large share of commonly used entry 
points for identification of mouse models. For example, 
all Centers participate in the archiving and distribution 
of knockout mouse models generated by the NIH Knock-
out Mouse Production and Phenotyping (KOMP2) Pro-
ject (https:// commo nfund. nih. gov/ komp2) (Bradley 2012; 
Birling 2021). In coordination with its global partners, 
KOMP2 is working to produce and phenotype mouse 
lines of male and female mice expressing null alleles for 
every human orthologous gene in the mouse genome. The 
MMRRC Program is now the primary archive and distri-
bution repository for all KOMP2 products, including mice, 
germplasm, ES cells, targeting vectors, and tissue samples. 
Investigators seek out these popular knockout mouse lines 
available at a nominal cost, which is much simpler and 
faster than making them again in their own laboratories.
In addition, the MMRRC Program actively integrates 
with resources and providers of other animal species to pro-
mote scientific advances benefiting human health. For exam-
ple, the MMRRC Program shares its mouse phenotype and 
genotype data with the MONARCH Initiative (McMurry 
2016) to enable semantically integrated computational anal-
ysis across mouse and other research animal species that 
improves understanding the pathophysiology and genetics 
of human disease. These activities are essential to maximize 
the application of knowledge gained from studying mouse 
models to inform and improve human health.
Technology transfer
The MMRRC Program has developed online Conditions of 
Use (COU) and Material Transfer Agreement (MTA) forms 
that are used for transferring mouse stocks into and out of 
the Centers. These documents have been developed after 
input from the community, with the Center’s host institu-
tional officials, and with NIH technology transfer officers. 
The paperless COU and Donor MTA are designed to be 
time-efficient and eco-friendly, paperless forms. The Donor 
MTA can be printed if electronic signatures are not accept-
able to a donating institution. All documents must be signed 
by an authorized Technology Transfer representative from 
the requesting or donating institution, and where applicable 
counter-signed by a designated Center official before the 
submission or request is processed. The MMRRC Program 
facilitates distribution of mice and materials not only to aca-
demic users but also to other non-profit and commercial, 
for-profit entities such as the biotechnology and biophar-
maceutical sectors.
Rigor, reproducibility, and transparency
Although reproducibility of experimental studies using 
mice has improved significantly from earlier (Perrin 2014), 
centralized mouse repository systems remain a critical 
and essential component to ensure the reliability of mouse 
models for biomedical research. The MMRRC Program is a 
critical component of the NIH’s initiative to optimize rigor, 
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reproducibility and transparency in biomedical research that 
uses mouse models (Lloyd 2015). Centers in the MMRRC 
Consortium are committed to upholding the highest stand-
ards of experimental design and quality control to optimize 
the reproducibility of research studies using mutant mice. 
For example, understanding, documenting, and accurately 
reporting the genetic backgrounds of mouse models used in 
research is essential for recreating an experimental study and 
achieving reproducible results. Specific quality control and 
assurance testing processes, such as full genetic annotation 
and documentation of each MMRRC mouse, are in place at 
each Center. Also, as all Centers have committed to main-
taining specific-pathogen-free vivaria and quality control 
measures, investigators can rely on mice obtained from the 
Centers to generate reproducible results. Specifically, the 
Centers address the NIH’s focus on rigor, reproducibility, 
and transparency by adhering to the following principles:
• Scientific Premise—the MMRRC Program provides 
genetically engineered mouse models for virtually every 
field of biomedical research ranging from neurobiology 
to infectious disease. These mouse models are critical to 
the advancement of understanding of health and disease.
• Rigorous Experimental Design—the MMRRC Provides 
authentic and key biological resources that are easily 
reported and described using unique identifiers (e.g., 
RRID numbers) to ensure full transparency so that oth-
ers may obtain the same models with which to reproduce 
studies.
• Consideration of Relevant Biological Variables—models 
obtained from Centers in the MMRRC Consortium are 
genetically defined (including background strain genet-
ics, incipient congenic strains and congenic strains) and 
confirmed specific pathogen free. Moreover, individual 
Centers have extensive expertise in troubleshooting 
how other biological variables, such as husbandry fac-
tors, microbiota and sex, may modulate phenotypes. By 
obtaining mice from the MMRRC Program, investigators 
eliminate the risk of genetic drift or contamination with 
adventitious pathogens that potentially can arise through 
the use of long standing in-house colonies or obtaining 
mice from colleagues. In addition, the MMRRC Pro-
gram supports the NC3R’s ARRIVE (Animal Research: 
Reporting of In Vivo Experiments, https:// arriv eguid 
elines. org/) initiative to improve the reporting of research 
using animals (Kilkenny 2010). The MMRRC Program 
stands behind and supports efforts with 3R develop-
ment, training, and advances and adheres to standardized 
reporting guidelines.
• Authentication of Mice Using the Strain Detail Sheet. 
Genetic, phenotypic, husbandry, and other scientific and 
research-relevant information on each mutant mouse line 
accepted by the MMRRC Program is documented on the 
MMRRC Strain Detail Sheet (SDS). Each mouse line has a 
unique SDS page where information provided by the donat-
ing investigator, such as specific information curated by the 
ICSC, relevant genotyping protocols and specifics about 
husbandry, care, and management can be found. In addi-
tion, users can find information on availability and prices, 
including fees for shipping and handling, for available 
product items. The online request form can be accessed 
directly from a mouse line’s SDS page.
• Moving Rigor and Reproducibility Forward. The MMRRC 
Program is at the forefront of developing and implement-
ing novel broad-based strategies to optimize rigor and 
reproducibility of research using mouse models. Two key 
examples are (1) the development, refinement and appli-
cation of miniMUGA for the assessment and confirma-
tion of background strain/substrain of mutant mice and 
(2) investment in studies designed to understand the role 
of microbiota on model phenotypes and to develop tools 
that aid investigators in considering microbiota in model 
reproducibility troubleshooting and optimization. Centers 
in the MMRRC Consortium have adopted the highest qual-
ity control standards to ensure the fidelity and reliability 
of mouse models they distribute. As stated previously, all 
incoming lines undergo verification and characterization 
by a thorough physical exam by trained technicians con-
ducting noting morphological observations, gene-specific 
genotyping of DNA extracted from tail snips, background 
strain analysis using miniMUGA genome-wide genotyp-
ing, 16s gut microbiome analysis, and pathogen surveil-
lance via microbiological culture, PCR, and examination 
for parasites. Breeding performance, fertility, viability, and 
sexual dimorphism is noted and recorded while verifying 
the recoverability of newly cryopreserved germplasm. 
If not already available, a newly deposited mouse line is 
assigned a unique RRID number and listed with its full 
descriptive characteristics, use protocols, and available 
formats in the online catalog, linked to scientific refer-
ences and associated databases. Upon request, a Center 
will attempt to recapitulate research-relevant phenotypes 
indicated by the submitting investigator, and importantly 
reveal any new or previously unknown phenotypes. When 
requested as live mice, strains are rederived and maintained 
in dedicated vivaria with strict pathogen control systems in 
place to prevent contamination by adventitious pathogens.
Disaster planning to preserve and protect 
from catastrophic loss
Considering the steep investment over time, the scientific 
and unique value of the resource, and operating principles 
that minimize duplicative effort and redundant spending to 
maintain mutant mouse lines for distribution at more than 
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one site, Centers in the MMRRC Consortium have made 
strategic investments to minimize losses in the event of 
unforeseen disasters, such as loss of power, fire, flooding, or 
data breach. For example, Centers split their frozen archive 
between different tanks and geographic sites, including at 
the National Animal Germplasm Program (NAGP) which 
is a part of the National Laboratory for Genetic Resources 
Preservation (NLGRP) located in Fort Collins, Colorado, 
USA (Kaplan 2016). Electrical power supplying the vivaria, 
storage tanks, and data servers are provided full 100% 
backup using dedicated electrical generators. Fire suppres-
sion systems are in place and monitored 24/7/365 by host 
institution security services, and systems are regularly tested 
to verify functionality. All data servers are monitored by 
online cloud services and monthly backups (e.g., tape) are 
made and stored at distant secure sites for complete data 
restoration if needed. These and other security practices 
ensure the preservation of the resource and shared between 
all Centers in the MMRRC Consortium.
Resource sharing plan
The MMRRC Program was also established as a means to 
implement the NIH Sharing Plans for Resources and Data. 
Its prime directive is to encourage submission and deposi-
tion of unique mutant mouse resources developed through 
NIH-sponsored research into the MMRRC Program from 
where they are made readily available to scientists qualified 
and approved by their institutions to use mice for research 
purposes. The ICSC makes all mouse resources and geno-
type, health, husbandry information, phenotype, and other 
relevant data (including meta-analysis data) available on the 
SDS. Submitted data are confirmed with relevant data and 
terminology standards. All data are made publicly available 
after curation, assignment of an RRID number, and listing 
the strain in the MMRRC online catalog, usually within 
30 days of receipt of information and mice from the sub-
mitting investigator. The ICSC provides investigators with 
standard language to include in publications that identify 
where mutant mice and data are available, how to access 
data on the MMRRC Program website (www. mmrrc. org), 
and how to acknowledge the MMRRC Program and NIH 
funding source.
The future of the MMRRC program
The MMRRC Program will continue its active leadership 
and engagement as the leading public national mouse reposi-
tory system in the USA. This includes continuing emphasis 
on providing research scientists with the most appropriate, 
valid, and reliable mutant mouse models and services using 
next-generation technologies (e.g., CRISPR) for well-justi-
fied, scientifically sound, and reproducible research.
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